Bio-active Lipid II Screening Library (96-Well)
Cayman Chemical Item Number 10507
Bio-active Lipid II Screening Library (96-Well)
Description
This screening library consists of 3 plates and contains 219 compounds that include prostaglandins, isoprostanes, thromboxanes, leukotrienes, lipoxins and several other complex polyunsaturated fatty acids. This collection is ideal for prostanoid or other G protein-coupled receptor screening, target validation, secondary screening, validating new assays and for routine pharmacological applications. The library is provided in a 96-well format as 0.1 mM solution in DMSO. The composition of the library will always vary somewhat depending upon our inventory.
| Formulation |
A 0.1 mM solution in DMSO |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
Wet ice
in continental US; may vary elsewhere
|
Library Contents
| Sort |
Plate |
Well |
Contents |
| 0 | 1 |
A1 |
Unused
|
| 1 | 1 |
A2 |
5(S),6(R)-Lipoxin A4 methyl ester
|
| 2 | 1 |
A3 |
tetranor-PGEM
|
| 3 | 1 |
A4 |
2,3-dinor-11β-Prostaglandin F2α
|
| 4 | 1 |
A5 |
Prostaglandin G2
|
| 5 | 1 |
A6 |
Leukotriene A3 methyl ester
|
| 6 | 1 |
A7 |
20-carboxy Leukotriene B4
|
| 7 | 1 |
A8 |
Prostaglandin A3
|
| 8 | 1 |
A9 |
9(S)-HEPE
|
| 9 | 1 |
A10 |
15(S)-HEPE
|
| 10 | 1 |
A11 |
Unused
|
| 11 | 1 |
A12 |
Unused
|
| 12 | 1 |
B1 |
Unused
|
| 13 | 1 |
B2 |
5(S),6(S)-Lipoxin A4
|
| 14 | 1 |
B3 |
19(R)-hydroxy Prostaglandin E2
|
| 15 | 1 |
B4 |
Prostaglandin A1-biotin
|
| 16 | 1 |
B5 |
Prostaglandin H1
|
| 17 | 1 |
B6 |
Leukotriene A4 methyl ester
|
| 18 | 1 |
B7 |
20-hydroxy Leukotriene B4
|
| 19 | 1 |
B8 |
Prostaglandin D3
|
| 20 | 1 |
B9 |
(±)11-HEPE
|
| 21 | 1 |
B10 |
(±)18-HEPE
|
| 22 | 1 |
B11 |
(±)16-HDoHE
|
| 23 | 1 |
B12 |
Unused
|
| 24 | 1 |
C1 |
Unused
|
| 25 | 1 |
C2 |
(±)12-HpETE
|
| 26 | 1 |
C3 |
15(R),19(R)-hydroxy Prostaglandin E2
|
| 27 | 1 |
C4 |
Unused
|
| 28 | 1 |
C5 |
Prostaglandin H2
|
| 29 | 1 |
C6 |
Unused
|
| 30 | 1 |
C7 |
MK 571
|
| 31 | 1 |
C8 |
Leukotriene F4
|
| 32 | 1 |
C9 |
11(R)-HEPE
|
| 33 | 1 |
C10 |
(±)4-HDoHE
|
| 34 | 1 |
C11 |
(±)17-HDoHE
|
| 35 | 1 |
C12 |
Unused
|
| 36 | 1 |
D1 |
Unused
|
| 37 | 1 |
D2 |
15(S)-HETE Ethanolamide
|
| 38 | 1 |
D3 |
20-hydroxy Prostaglandin E2
|
| 39 | 1 |
D4 |
19(R)-hydroxy Prostaglandin F2α
|
| 40 | 1 |
D5 |
13,14-dehydro-15-cyclohexyl Carbaprostacyclin
|
| 41 | 1 |
D6 |
Leukotriene B4
|
| 42 | 1 |
D7 |
PGPC
|
| 43 | 1 |
D8 |
Unused
|
| 44 | 1 |
D9 |
11(S)-HEPE
|
| 45 | 1 |
D10 |
(±)7-HDoHE
|
| 46 | 1 |
D11 |
Unused
|
| 47 | 1 |
D12 |
Unused
|
| 48 | 1 |
E1 |
Unused
|
| 49 | 1 |
E2 |
14(15)-EpETE
|
| 50 | 1 |
E3 |
Unused
|
| 51 | 1 |
E4 |
15(R),19(R)-hydroxy Prostaglandin F2α
|
| 52 | 1 |
E5 |
2,3-dinor Thromboxane B2
|
| 53 | 1 |
E6 |
Leukotriene B4 Ethanolamide
|
| 54 | 1 |
E7 |
15-deoxy-Δ12,14-Prostaglandin J2-biotin
|
| 55 | 1 |
E8 |
5(S)-HEPE
|
| 56 | 1 |
E9 |
(±)12-HEPE
|
| 57 | 1 |
E10 |
(±)8-HDoHE
|
| 58 | 1 |
E11 |
(±)5-HETE
|
| 59 | 1 |
E12 |
Unused
|
| 60 | 1 |
F1 |
Unused
|
| 61 | 1 |
F2 |
16(17)-EpDPE
|
| 62 | 1 |
F3 |
2,3-dinor-8-iso Prostaglandin F2α
|
| 63 | 1 |
F4 |
20-hydroxy Prostaglandin F2α
|
| 64 | 1 |
F5 |
11-dehydro-2,3-dinor Thromboxane B2
|
| 65 | 1 |
F6 |
Leukotriene B4 dimethyl amide
|
| 66 | 1 |
F7 |
HPF
|
| 67 | 1 |
F8 |
(±)8-HEPE
|
| 68 | 1 |
F9 |
12(R)-HEPE
|
| 69 | 1 |
F10 |
(±)10-HDoHE
|
| 70 | 1 |
F11 |
(±)5-HETE lactone
|
| 71 | 1 |
F12 |
Unused
|
| 72 | 1 |
G1 |
Unused
|
| 73 | 1 |
G2 |
19(20)-EpDPE
|
| 74 | 1 |
G3 |
Unused
|
| 75 | 1 |
G4 |
8-iso Prostaglandin F3α
|
| 76 | 1 |
G5 |
Thromboxane B3
|
| 77 | 1 |
G6 |
12-epi Leukotriene B3
|
| 78 | 1 |
G7 |
13-epi-12-oxo Phytodienoic Acid
|
| 79 | 1 |
G8 |
8(S)-HEPE
|
| 80 | 1 |
G9 |
Unused
|
| 81 | 1 |
G10 |
(±)11-HDoHE
|
| 82 | 1 |
G11 |
(±)5-HETE methyl ester
|
| 83 | 1 |
G12 |
Unused
|
| 84 | 1 |
H1 |
Unused
|
| 85 | 1 |
H2 |
2,3-dinor Prostaglandin E1
|
| 86 | 1 |
H3 |
Δ17-U-46619
|
| 87 | 1 |
H4 |
17-trans Prostaglandin F3α
|
| 88 | 1 |
H5 |
11-dehydro Thromboxane B3
|
| 89 | 1 |
H6 |
12-epi Leukotriene B4
|
| 90 | 1 |
H7 |
19(R)-hydroxy Prostaglandin A2
|
| 91 | 1 |
H8 |
(±)9-HEPE
|
| 92 | 1 |
H9 |
(±)15-HEPE
|
| 93 | 1 |
H10 |
Unused
|
| 94 | 1 |
H11 |
Unused
|
| 95 | 1 |
H12 |
Unused
|
| 96 | 2 |
A1 |
Unused
|
| 97 | 2 |
A2 |
5(S)-HETE
|
| 98 | 2 |
A3 |
(±)11-HETE
|
| 99 | 2 |
A4 |
Unused
|
| 100 | 2 |
A5 |
Unused
|
| 101 | 2 |
A6 |
11(S)-HEDE
|
| 102 | 2 |
A7 |
13-OxoODE
|
| 103 | 2 |
A8 |
15(S)-HpEDE
|
| 104 | 2 |
A9 |
(±)8,9-DHET
|
| 105 | 2 |
A10 |
U-75302
|
| 106 | 2 |
A11 |
4,5-dehydro Docosahexaenoic Acid
|
| 107 | 2 |
A12 |
Unused
|
| 108 | 2 |
B1 |
Unused
|
| 109 | 2 |
B2 |
5(S)-HETE lactone
|
| 110 | 2 |
B3 |
11(R)-HETE
|
| 111 | 2 |
B4 |
(±)15-HETE
|
| 112 | 2 |
B5 |
5(S),15(S)-DiHETE
|
| 113 | 2 |
B6 |
(±)15-HEDE
|
| 114 | 2 |
B7 |
13(S)-HOTrE(γ)
|
| 115 | 2 |
B8 |
(±)5(6)-EET
|
| 116 | 2 |
B9 |
(±)11,12-DHET
|
| 117 | 2 |
B10 |
PtdIns-(5)-P1 (1,2-dipalmitoyl) (ammonium salt)
|
| 118 | 2 |
B11 |
4(5)-EpDPE methyl ester
|
| 119 | 2 |
B12 |
Unused
|
| 120 | 2 |
C1 |
Unused
|
| 121 | 2 |
C2 |
Unused
|
| 122 | 2 |
C3 |
11(S)-HETE
|
| 123 | 2 |
C4 |
15(R)-HETE
|
| 124 | 2 |
C5 |
8(S),15(S)-DiHETE
|
| 125 | 2 |
C6 |
15(R)-HEDE
|
| 126 | 2 |
C7 |
5(S)-HpEPE
|
| 127 | 2 |
C8 |
(±)8(9)-EET
|
| 128 | 2 |
C9 |
(±)14,15-DHET
|
| 129 | 2 |
C10 |
Lactacystin
|
| 130 | 2 |
C11 |
5(S),6(R)-Lipoxin A4
|
| 131 | 2 |
C12 |
Unused
|
| 132 | 2 |
D1 |
Unused
|
| 133 | 2 |
D2 |
PtdIns-(3,4,5)-P3 (1,2-dipalmitoyl) (sodium salt)
|
| 134 | 2 |
D3 |
(±)12-HETE
|
| 135 | 2 |
D4 |
15(S)-HETE
|
| 136 | 2 |
D5 |
5(S)-HETrE
|
| 137 | 2 |
D6 |
15(S)-HEDE
|
| 138 | 2 |
D7 |
12(S)-HpEPE
|
| 139 | 2 |
D8 |
(±)11(12)-EET
|
| 140 | 2 |
D9 |
(±)9(10)-EpOME
|
| 141 | 2 |
D10 |
Calcitriol
|
| 142 | 2 |
D11 |
11-dehydro Thromboxane B2-d4
|
| 143 | 2 |
D12 |
Unused
|
| 144 | 2 |
E1 |
Unused
|
| 145 | 2 |
E2 |
(±)8-HETE
|
| 146 | 2 |
E3 |
Unused
|
| 147 | 2 |
E4 |
15-OxoETE
|
| 148 | 2 |
E5 |
8(S)-HETrE
|
| 149 | 2 |
E6 |
15-OxoEDE
|
| 150 | 2 |
E7 |
15(S)-HpEPE
|
| 151 | 2 |
E8 |
(±)14(15)-EET
|
| 152 | 2 |
E9 |
(±)12(13)-EpOME
|
| 153 | 2 |
E10 |
Unused
|
| 154 | 2 |
E11 |
14,15-EE-5(Z)-E
|
| 155 | 2 |
E12 |
Unused
|
| 156 | 2 |
F1 |
Unused
|
| 157 | 2 |
F2 |
(±)9-HETE
|
| 158 | 2 |
F3 |
tetranor-12(R)-HETE
|
| 159 | 2 |
F4 |
5(S),6(R)-DiHETE
|
| 160 | 2 |
F5 |
15(S)-HETrE
|
| 161 | 2 |
F6 |
9(R)-HODE
|
| 162 | 2 |
F7 |
5(S)-HpETE
|
| 163 | 2 |
F8 |
17(18)-EpETE
|
| 164 | 2 |
F9 |
(±)9,10-DiHOME
|
| 165 | 2 |
F10 |
5,6-dehydro Arachidonic Acid
|
| 166 | 2 |
F11 |
Unused
|
| 167 | 2 |
F12 |
Unused
|
| 168 | 2 |
G1 |
Unused
|
| 169 | 2 |
G2 |
9(R)-HETE
|
| 170 | 2 |
G3 |
12(S)-HETE
|
| 171 | 2 |
G4 |
5(S),6(S)-DiHETE
|
| 172 | 2 |
G5 |
(±)11-HEDE
|
| 173 | 2 |
G6 |
9-OxoODE
|
| 174 | 2 |
G7 |
12(S)-HpETE
|
| 175 | 2 |
G8 |
(±)5,6-DHET
|
| 176 | 2 |
G9 |
PtdIns-(3,4)-P2 (1,2-dipalmitoyl) (sodium salt)
|
| 177 | 2 |
G10 |
20-HETE
|
| 178 | 2 |
G11 |
2,3-dinor Thromboxane B1
|
| 179 | 2 |
G12 |
Unused
|
| 180 | 2 |
H1 |
Unused
|
| 181 | 2 |
H2 |
9(S)-HETE
|
| 182 | 2 |
H3 |
Unused
|
| 183 | 2 |
H4 |
6-trans Leukotriene B4
|
| 184 | 2 |
H5 |
11(R)-HEDE
|
| 185 | 2 |
H6 |
13(R)-HODE
|
| 186 | 2 |
H7 |
15(S)-HpETE
|
| 187 | 2 |
H8 |
(±)5,6-DHET lactone
|
| 188 | 2 |
H9 |
PtdIns-(4)-P1 (1,2-dipalmitoyl) (ammonium salt)
|
| 189 | 2 |
H10 |
5(6)-EpETE methyl ester
|
| 190 | 2 |
H11 |
Prostaglandin D2-biotin
|
| 191 | 2 |
H12 |
Unused
|
| 192 | 3 |
A1 |
Unused
|
| 193 | 3 |
A2 |
13,14-dihydro-19(R)-hydroxy Prostaglandin E1
|
| 194 | 3 |
A3 |
15(R),19(R)-hydroxy Prostaglandin E1
|
| 195 | 3 |
A4 |
(±)5(6)-EET Ethanolamide
|
| 196 | 3 |
A5 |
16,16-dimethyl Prostaglandin E2 p-(p-acetamidobenzamido) phenyl ester
|
| 197 | 3 |
A6 |
8-iso-13,14-dihydro-15-keto Prostaglandin F2α
|
| 198 | 3 |
A7 |
Carbaprostacyclin
|
| 199 | 3 |
A8 |
I-SAP
|
| 200 | 3 |
A9 |
13(S)-HOTrE
|
| 201 | 3 |
A10 |
D-myo-Inositol-1,3,4,5-tetraphosphate (sodium salt)
|
| 202 | 3 |
A11 |
D-myo-Inositol-1,3-diphosphate (sodium salt)
|
| 203 | 3 |
A12 |
Unused
|
| 204 | 3 |
B1 |
Unused
|
| 205 | 3 |
B2 |
Prostaglandin E2-biotin
|
| 206 | 3 |
B3 |
Prostaglandin E2 p-benzamidophenyl ester
|
| 207 | 3 |
B4 |
(±)8(9)-EET Ethanolamide
|
| 208 | 3 |
B5 |
Unused
|
| 209 | 3 |
B6 |
8-iso-15-keto Prostaglandin F2α
|
| 210 | 3 |
B7 |
Iloprost
|
| 211 | 3 |
B8 |
11-dehydro Thromboxane B2
|
| 212 | 3 |
B9 |
9(S)-HpOTrE
|
| 213 | 3 |
B10 |
D-myo-Inositol-1,2,3,5-tetraphosphate (sodium salt)
|
| 214 | 3 |
B11 |
Unused
|
| 215 | 3 |
B12 |
Unused
|
| 216 | 3 |
C1 |
Unused
|
| 217 | 3 |
C2 |
Prostaglandin F2α-biotin
|
| 218 | 3 |
C3 |
tetranor-12(S)-HETE
|
| 219 | 3 |
C4 |
(±)11(12)-EET Ethanolamide
|
| 220 | 3 |
C5 |
(±)12,13-DiHOME
|
| 221 | 3 |
C6 |
U-51605
|
| 222 | 3 |
C7 |
Ciprostene (calcium salt)
|
| 223 | 3 |
C8 |
I-BOP
|
| 224 | 3 |
C9 |
13(S)-HpOTrE(γ)
|
| 225 | 3 |
C10 |
D-myo-Inositol-2,4-diphosphate (sodium salt)
|
| 226 | 3 |
C11 |
D-myo-Inositol-1,2,3,4-tetraphosphate (sodium salt)
|
| 227 | 3 |
C12 |
Unused
|
| 228 | 3 |
D1 |
Unused
|
| 229 | 3 |
D2 |
(±)14,15-DiHETE
|
| 230 | 3 |
D3 |
20-carboxy Arachidonic Acid
|
| 231 | 3 |
D4 |
(±)14(15)-EET Ethanolamide
|
| 232 | 3 |
D5 |
Prostaglandin E3
|
| 233 | 3 |
D6 |
11β-13,14-dihydro-15-keto Prostaglandin F2α
|
| 234 | 3 |
D7 |
Prostaglandin I3 (sodium salt)
|
| 235 | 3 |
D8 |
(±)9-HODE
|
| 236 | 3 |
D9 |
13(S)-HpOTrE
|
| 237 | 3 |
D10 |
PtdIns-(4,5)-P2 (1,2-dioctanoyl) (sodium salt)
|
| 238 | 3 |
D11 |
PtdIns-(3)-P1 (1,2-dipalmitoyl) (ammonium salt)
|
| 239 | 3 |
D12 |
Unused
|
| 240 | 3 |
E1 |
Unused
|
| 241 | 3 |
E2 |
(±)17,18-DiHETE
|
| 242 | 3 |
E3 |
9-Nitrooleate
|
| 243 | 3 |
E4 |
20-HETE Ethanolamide
|
| 244 | 3 |
E5 |
2,3-dinor-6-keto Prostaglandin F1α (sodium salt)
|
| 245 | 3 |
E6 |
Fluprostenol isopropyl ester
|
| 246 | 3 |
E7 |
Unused
|
| 247 | 3 |
E8 |
Unused
|
| 248 | 3 |
E9 |
Cholesteryl Linoleate Hydroperoxides
|
| 249 | 3 |
E10 |
D-myo-Inositol-1,2,3,6-tetraphosphate (sodium salt)
|
| 250 | 3 |
E11 |
D-myo-Inositol-2,3,4,5-tetraphosphate (ammonium salt)
|
| 251 | 3 |
E12 |
Unused
|
| 252 | 3 |
F1 |
Unused
|
| 253 | 3 |
F2 |
(±)19,20-DiHDPA
|
| 254 | 3 |
F3 |
10-Nitrooleate
|
| 255 | 3 |
F4 |
tetranor-PGDM-d6
|
| 256 | 3 |
F5 |
Δ17-6-keto Prostaglandin F1α
|
| 257 | 3 |
F6 |
5-trans Fluprostenol isopropyl ester
|
| 258 | 3 |
F7 |
Prostaglandin K1
|
| 259 | 3 |
F8 |
(±)13-HODE
|
| 260 | 3 |
F9 |
9(S)-HpODE
|
| 261 | 3 |
F10 |
D-myo-Inositol-4-phosphate (ammonium salt)
|
| 262 | 3 |
F11 |
D-myo-Inositol-1,2,4,5,6-pentaphosphate (sodium salt)
|
| 263 | 3 |
F12 |
Unused
|
| 264 | 3 |
G1 |
Unused
|
| 265 | 3 |
G2 |
11β-Misoprostol
|
| 266 | 3 |
G3 |
8-iso-15-keto Prostaglandin E2
|
| 267 | 3 |
G4 |
9-OxoOTrE
|
| 268 | 3 |
G5 |
6,15-diketo-13,14-dihydro Prostaglandin F1α
|
| 269 | 3 |
G6 |
15(S)-Fluprostenol isopropyl ester
|
| 270 | 3 |
G7 |
Prostaglandin K2
|
| 271 | 3 |
G8 |
13(S)-HODE
|
| 272 | 3 |
G9 |
13(S)-HpODE
|
| 273 | 3 |
G10 |
D-myo-Inositol-1,4-diphosphate (sodium salt)
|
| 274 | 3 |
G11 |
D-myo-Inositol-1,2,4,5-tetraphosphate (sodium salt)
|
| 275 | 3 |
G12 |
Unused
|
| 276 | 3 |
H1 |
Unused
|
| 277 | 3 |
H2 |
19(R)-hydroxy Prostaglandin E1
|
| 278 | 3 |
H3 |
PtdIns-(3)-P1 (1,2-dioctanoyl) (sodium salt)
|
| 279 | 3 |
H4 |
11β-Prostaglandin E2
|
| 280 | 3 |
H5 |
19(R)-hydroxy Prostaglandin F1α
|
| 281 | 3 |
H6 |
Prostaglandin F3α
|
| 282 | 3 |
H7 |
Carbocyclic Thromboxane A2
|
| 283 | 3 |
H8 |
9(S)-HOTrE
|
| 284 | 3 |
H9 |
D-myo-Inositol-1,4,5-triphosphate (potassium salt)
|
| 285 | 3 |
H10 |
D-myo-Inositol-1,5-diphosphate (sodium salt)
|
| 286 | 3 |
H11 |
D-myo-Inositol-3,4,5-triphosphate (sodium salt)
|
| 287 | 3 |
H12 |
Unused
|
|
Pricing updated 2012-02-11.
Prices are subject to change without notice.
To ask for assistance with one of our products please contact a Technical Support Scientist.
Warning This product is not for human or veterinary use.
Show all 5
Hide all but first 3
Downloads
Batch-specific Information
Login
to access batch-specific information
|
|
Cayman Chemical is a manufacturer, supplier and vendor of biochemical reagents, assay kits, antibodies, and proteins.
|